Division of Epidemiology, Department of Family Medicine and Public Health, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA.
Kaiser Permanente Washington Health Research Institute, 1730 Minor Avenue, Suite 1600, Seattle, WA, 98101, USA.
BMC Geriatr. 2017 Nov 2;17(1):258. doi: 10.1186/s12877-017-0637-7.
Mechanisms linking cognitive and physical functioning in older adults are unclear. We sought to determine whether brain pathological changes relate to the level or rate of physical performance decline.
This study analyzed data from 305 participants in the autopsy subcohort of the prospective Adult Changes in Thought (ACT) study. Participants were aged 65+ and free of dementia at enrollment. Physical performance was measured at baseline and every two years using the Short Physical Performance Battery (SPPB). Data from 3174 ACT participants with ≥2 SPPB measurements were used to estimate two physical function measures: 1) rate of SPPB decline defined by intercept and slope; and 2) estimated SPPB 5 years prior to death. Neuropathology findings at autopsy included neurofibrillary tangles (Braak stage), neuritic plaques (CERAD level), presence of amyloid angiopathy, microinfarcts, cystic infarcts, and Lewy bodies. Associations (adjusted for sex, age, body mass index and education) between dichotomized neuropathologic outcomes and SPPB measures were estimated using modified Poisson regression with inverse probability weights (IPW) estimated via Generalized Estimating Equations (GEE). Relative risks for the 20, 40, and 60 percentiles (lowest levels and highest rates of decline) relative to the 80th percentile (highest level and lowest rate of decline) were calculated.
Decedents with the least vs. most SPPB decline (slope > 75 vs. < 25 percentiles) had higher SPPB scores, and were more likely to be male, older, have higher education, and exercise regularly at baseline. No significant associations were observed between neuropathology findings and rate of SPPB decline. Lower predicted SPPB scores 5 years prior to death were associated with higher risk of microinfarcts (RR = 3.08, 95% confidence interval (CI) 0.93-1.07 for the 20 vs. 80 percentiles of SPPB) and significantly higher risk of cystic infarcts (RR = 2.72, 95% CI 1.45-5.57 for 20 vs. 80 percentiles of SPPB).
Cystic infarcts and microinfarcts, but not neuropathology findings of Alzheimer's disease, were related to physical performance levels five years before death. No pathology findings were associated with rates of physical performance decline. Physical function levels in the years prior to death may be affected by vascular brain pathologies.
认知功能和身体功能之间的联系机制在老年人中尚不清楚。我们试图确定大脑病理变化是否与身体功能下降的程度或速度有关。
本研究分析了前瞻性成人思维变化(ACT)研究尸检亚队列中 305 名参与者的数据。参与者年龄在 65 岁及以上,入组时无痴呆。身体功能在基线时和每两年使用简短身体表现测试(SPPB)进行测量。使用来自 3174 名具有≥2 次 SPPB 测量值的 ACT 参与者的数据来估计两个身体功能指标:1)SPPB 下降率,由截距和斜率定义;2)死亡前 5 年的估计 SPPB。尸检中的神经病理学发现包括神经纤维缠结(Braak 分期)、神经原纤维缠结(CERAD 分级)、淀粉样血管病、微梗死、囊性梗死和路易体。使用改良泊松回归和广义估计方程(GEE)估计的逆概率权重(IPW)(调整性别、年龄、体重指数和教育),对二分神经病理学结果和 SPPB 指标之间的相关性进行了估计。计算与 SPPB 最低水平和最高下降率(80%百分位以下)相比,20%、40%和 60%百分位(最低水平和最高下降率)的相对风险。
与 SPPB 下降斜率最大(>75%)相比,下降最慢(<25%)的死者 SPPB 评分更高,更有可能为男性,年龄更大,教育程度更高,并且在基线时经常锻炼。神经病理学发现与 SPPB 下降率之间无显著相关性。死亡前 5 年预测的 SPPB 评分较低与微梗死的风险增加相关(RR=3.08,95%CI 0.93-1.07,20%与 80% SPPB 百分位),与囊性梗死的风险显著增加相关(RR=2.72,95%CI 1.45-5.57,20%与 80% SPPB 百分位)。
囊性梗死和微梗死,但不是阿尔茨海默病的神经病理学发现,与死亡前 5 年的身体表现水平有关。没有病理学发现与身体功能下降的速度有关。死亡前几年的身体功能水平可能受脑血管病理学的影响。